These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 12966622
1. Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial. Lodder MC, Van Pelt PA, Lems WF, Kostense PJ, Koks CH, Dijkmans BA. J Rheumatol; 2003 Sep; 30(9):2080-1. PubMed ID: 12966622 [No Abstract] [Full Text] [Related]
2. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BA, Breedveld FC. J Rheumatol; 1994 Nov; 21(11):2016-20. PubMed ID: 7869303 [Abstract] [Full Text] [Related]
3. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial. van der Laan W, Molenaar E, Ronday K, Verheijen J, Breedveld F, Greenwald R, Dijkmans B, TeKoppele J. J Rheumatol; 2001 Sep; 28(9):1967-74. PubMed ID: 11550961 [Abstract] [Full Text] [Related]
4. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP. J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645 [Abstract] [Full Text] [Related]
5. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP. Rheumatology (Oxford); 2007 Dec; 46(12):1773-8. PubMed ID: 17965442 [Abstract] [Full Text] [Related]
6. Effects of clarithromycin in patients with active rheumatoid arthritis. Ogrendik M. Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733 [Abstract] [Full Text] [Related]
12. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group. Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555 [Abstract] [Full Text] [Related]
13. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial. Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M. J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385 [Abstract] [Full Text] [Related]
14. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R. Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771 [Abstract] [Full Text] [Related]
16. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Symmons D, Tricker K, Harrison M, Roberts C, Davis M, Dawes P, Hassell A, Knight S, Mulherin D, Scott DL, British Rheumatoid Outcome Study Group. Rheumatology (Oxford); 2006 May; 45(5):558-65. PubMed ID: 16263778 [Abstract] [Full Text] [Related]